This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.
Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...
Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...
Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.
The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in ...
Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...
Medtronic has announced US Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Affera ...
Madi, left, and Affera write letters to addiction at Camp Mariposa in Sarasota, Florida. Katie Kindelan/ABC News In some cases, like Madi's, campers have lost a parent to substance abuse ...
Affera, a 14-year-old camper in Sarasota, said she grew up watching her dad abuse alcohol. Through camp, she said she has learned that her dad's substance abuse issues are, "not because he doesn't ...